* If you want to update the article please login/register
Left ventricular function is a key determinant of patient care, success, and long-term survival of patients with heart disease. The most recent published clinical guidelines for heart failure recognize that over reliance on one measure of cardiac function as a diagnostic and treatment stratification biomarker is suboptimal. Recent advances in AI-based echocardiography analysis have yielded promising results on automated estimation of LV volumes and LV ejection fractions. However, from time-varying 2-D echocardiography acquisitions, a more accurate representation of cardiac function can be obtained by identifying functional biomarkers from the complete cardiac cycle. For the first time, we suggest an AI-based strategy for deriving advanced biomarkers of systolic and diastolic LV function from 2-D echocardiography segmentations based on segmentations of the complete cardiac cycle. The results show excellent agreement between manual and automated analysis, demonstrating the promise of the new systolic and diastolic biomarkers for patient stratification.
Source link: https://arxiv.org/abs/2203.11726v2
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions